New Results
Serostatus Testing & Dengue Vaccine Cost-Benefit Thresholds
Carl A. B. Pearson, View ORCID ProfileSamuel Clifford, View ORCID ProfileKaja M. Abbas, View ORCID ProfileStefan Flasche, View ORCID ProfileThomas J. Hladish
doi: https://doi.org/10.1101/594556
Carl A. B. Pearson
1Department of Infectious Disease Epidemiology & Centre for Mathematical Modelling of Infectious Disease, London School of Hygiene & Tropical Medicine and South African Centre for Epidemiological Modelling and Analysis, Stellenbosch University
Samuel Clifford
2Department of Infectious Disease Epidemiology & Centre for Mathematical Modelling of Infectious Disease, London School of Hygiene & Tropical Medicine
Kaja M. Abbas
2Department of Infectious Disease Epidemiology & Centre for Mathematical Modelling of Infectious Disease, London School of Hygiene & Tropical Medicine
Stefan Flasche
2Department of Infectious Disease Epidemiology & Centre for Mathematical Modelling of Infectious Disease, London School of Hygiene & Tropical Medicine
Thomas J. Hladish
3Department of Biology & Emerging Pathogens Institute, University of Florida
Posted April 05, 2019.
Serostatus Testing & Dengue Vaccine Cost-Benefit Thresholds
Carl A. B. Pearson, Samuel Clifford, Kaja M. Abbas, Stefan Flasche, Thomas J. Hladish
bioRxiv 594556; doi: https://doi.org/10.1101/594556
Subject Area
Subject Areas
- Biochemistry (11753)
- Bioengineering (8752)
- Bioinformatics (29201)
- Biophysics (14974)
- Cancer Biology (12100)
- Cell Biology (17413)
- Clinical Trials (138)
- Developmental Biology (9422)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18309)
- Genetics (12245)
- Genomics (16804)
- Immunology (11869)
- Microbiology (28098)
- Molecular Biology (11596)
- Neuroscience (60975)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)